Mepyramine Maleate

马来酸美吡拉敏

Report date: 2022/08/09 18:05:58
NME

Base Information

Drug NameMepyramine Maleate
Drug Alias Name马来酸吡拉明mepiraminamepyraminum甲氧苄二胺Pyrilamine maleate +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine receptor antagonists
TargetsHistamine receptor
Therapy Area/IndicationsHypersensitivityPruritusSleep Initiation and Maintenance Disorders +[4] 
Global Approved IndicationsHypersensitivityPruritusSleep Initiation and Maintenance Disorders +[4] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1973/08/07
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPending
Originator CompaniesImpax Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesImpax Laboratories
Inactive CompaniesBeijing Dongfang Lvyuan Technology Development Co Ltd
Active IndicationsHypersensitivityPruritusSleep Initiation and Maintenance Disorders +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeD04AA02R06AC01
Related LinksWikipediaDrugBankKEGG